TABLE 1 ASTHMA AND COPD DRUGS MARKET, BY DISEASE, 2014-2022 ($MILLION)
TABLE 2 ASTHMA AND COPD DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 3 COPD DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4 ASTHMA AND COPD DRUGS MARKET, BY MEDICATION CLASS TYPE, 2014-2022 ($MILLION)
TABLE 5 COMBINATION DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6 LTA DRUG MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 ICS DRUG MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 ANTICHOLINERGICS DRUG MARKET, BY GEOGRAPHY,
TABLE 9 2014-2022 ($MILLION)
TABLE 10 SABA DRUG MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 LABA DRUG MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12 OTHER DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 GLOBAL ASTHMA AND COPD DRUGS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 14 NORTH AMERICA: ASTHMA AND COPD DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15 NORTH AMERICA: ASTHMA AND COPD DRUGS MARKET, BY DISEASE, 2014-2022 ($MILLION)
TABLE 16 NORTH AMERICA: ASTHMA AND COPD DRUGS MARKET, BY MEDICATION CLASS, 2014-2022 ($MILLION)
TABLE 17 EUROPE: ASTHMA AND COPD DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 18 EUROPE: ASTHMA AND COPD DRUGS MARKET, BY DISEASE, 2014-2022 ($MILLION)
TABLE 19 EUROPE: ASTHMA AND COPD DRUGS MARKET, BY MEDICATION CLASS, 2014-2022 ($MILLION)
TABLE 20 ASIA-PACIFIC: ASTHMA AND COPD DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 21 ASIA-PACIFIC: ASTHMA AND COPD DRUGS MARKET, BY DISEASE, 2014-2022 ($MILLION)
TABLE 22 ASIA-PACIFIC: ASTHMA AND COPD DRUGS MARKET, BY MEDICATION CLASS, 2014-2022 ($MILLION)
TABLE 23 LAMEA: ASTHMA AND COPD DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24 LAMEA: ASTHMA AND COPD DRUGS MARKET, BY DISEASE, 2014-2022 ($MILLION)
TABLE 25 LAMEA: ASTHMA AND COPD DRUGS MARKET, BY MEDICATION CLASS, 2014-2022 ($MILLION)
TABLE 26 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 27 BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 28 MERCK: COMPANY SNAPSHOT
TABLE 29 MERCK: OPERATING SEGMENTS
TABLE 30 GSK: COMPANY SNAPSHOT
TABLE 31 GSK: OPERATING SEGMENTS
TABLE 32 NOVARTIS: COMPANY SNAPSHOT
TABLE 33 NOVARTIS: OPERATING SEGMENTS
TABLE 34 ASTRAZENECA: COMPANY SNAPSHOT
TABLE 35 ASTRAZENECA: OPERATING SEGMENT
TABLE 36 ROCHE: COMPANY SNAPSHOT
TABLE 37 ROCHE: OPERATING SEGMENTS
TABLE 38 TEVA: COMPANY SNAPSHOT
TABLE 39 TEVA: OPERATING SEGMENTS
TABLE 40 VECTURA: COMPANY SNAPSHOT
TABLE 41 VECTURA: OPERATING SEGMENTS
TABLE 42 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 43 PFIZER: OPERATING SEGMENTS
TABLE 44 ABBOTT: COMPANY SNAPSHOT
TABLE 45 ABBOTT: OPERATING SEGMENTS
LIST OF FIGURE
FIG. 1 TOP INVESTMENT POCKETS IN GLOBALASTHMA AND COPD DRUGS MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIG. 3 PORTERS FIVE FORCES ANALYSIS OF GLOBALASTHMA AND COPD DRUGS MARKET
FIG. 4 TOP IMPACTING FACTORS: GLOBALASTHMA AND COPD DRUGS MARKET
FIG. 5 GLOBALASTHMA AND COPD DRUGS MARKET, BY DISEASE, 2015 & 2022 (% SHARE)
FIG. 6 GLOBALASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 7 GLOBALASTHMA AND COPD DRUGS MARKET, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 8 COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 9 COPD DRUGS MARKET, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 10 SERETIDE/ADVAIT MARKET, 2014-2022 ($MILLION)
FIG. 11 SYMBICORT MARKET, 2014-2022 ($MILLION)
FIG. 12 RELVAR/BREO ELLIPTA MARKET, 2014-2022 ($MILLION)
FIG. 13 FLUTIFORM MARKET, 2014-2022 ($MILLION)
FIG. 14 FLUTIFORM MARKET, 2014-2022 ($MILLION)
FIG. 15 SINGULAIR MARKET, 2014-2022 ($MILLION)
FIG. 16 QVAR MARKET, 2014-2022 ($MILLION)
FIG. 17 PULMICORT MARKET, 2014-2022 ($MILLION)
FIG. 18 AEROSPAN MARKET, 2014-2022 ($MILLION)
FIG. 19 FLOVENT MARKET, 2014-2022 ($MILLION)
FIG. 20 SPIRIVA MARKET, 2014-2022 ($MILLION)
FIG. 21 PROAIR MARKET, 2014-2022 ($MILLION)
FIG. 22 PROAIR MARKET, 2014-2022 ($MILLION)
FIG. 23 U.S.: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 24 CANADA: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 25 MEXICO: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 26 GERMANY: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 27 FRANCE: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 28 UK: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 29 ITALY: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 30 REST OF EUROPE: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 31 JAPAN: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 32 CHINA: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 33 INDIA: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 34 REST OF ASIA-PACIFIC: ASTHMA AND COPD DRUGS DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 35 LATIN AMERICA: ASTHMA AND COPD DRUGSMARKET, 2014-2022 ($MILLION)
FIG. 36 MIDDLE EAST: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 37 AFRICA: ASTHMA AND COPD DRUGS MARKET, 2014-2022 ($MILLION)
FIG. 38 BOEHRINGER INGELHEIM: REVENUE, 2013-2015 ($MILLION)
FIG. 39 BOEHRINGER INGELHEIM: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 40 BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 41 MERCK: REVENUE, 2013-2015 ($MILLION)
FIG. 42 MERCK: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 43 MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 44 GSK: REVENUE, 2013-2015 ($MILLION)
FIG. 45 GSK: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 46 GSK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 47 NOVARTIS: REVENUE, 2013-2015 ($MILLION)
FIG. 48 NOVARTIS: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 49 NOVARTIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 50 ASTRAZENECA: REVENUE, 2013-2015 ($MILLION)
FIG. 51 ASTRAZENECA: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 52 ASTRAZENECA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 53 ROCHE: REVENUE, 2013-2015 ($MILLION)
FIG. 54 ROCHE: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 55 ROCHE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 56 TEVA: REVENUE, 2013-2015 ($MILLION)
FIG. 57 TEVA: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 58 TEVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 59 VECTURA: REVENUE, 2013-2015 ($MILLION)
FIG. 60 PFIZER: REVENUE, 2013-2015 ($MILLION)
FIG. 61 PFIZER: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 62 PFIZER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 63 ABBOTT: REVENUE, 2013-2015 ($MILLION)
FIG. 64 ABBOTT: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 65 ABBOTT: REVENUE, BY GEOGRAPHY, 2015 (%)